At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Philips FAST SpO2 with Masimo Pulse Oximetry Sensorsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation
In Brief
A clinical study evaluating Philips FAST SpO2 with Masimo Pulse Oximetry Sensors for Healthy. Completed, enrolled 70 participants across 1 site.
Detailed Summary
Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartNov 2023
First PostedNov 2023
Primary CompletionJan 2025
TodayJul 2026
First PostedNov 28, 2023
Enrollment StartNov 13, 2023
Primary CompletionJan 14, 2025
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.6 years ago
Interventions
Philips FAST SpO2 with Masimo Pulse Oximetry Sensorsdevice
Noninvasive pulse oximeter